Transthyretin Amyloid Cardiomyopathy Treatment Market Estimated to Witness High Growth Owing to Increasing Drug Approvals and Launch of Novel Therapies

The Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market is estimated to be valued at US$ 1.98 billion in 2027 and is expected to exhibit a CAGR of 31.1% over the forecast period 2020-2027, as highlighted in a new report published by Coherent Market Insights. Market Overview:Transthyretin amyloid cardiomyopathy (ATTR-CM) is a rare, progressive heart muscle disease … Read more

9 Essential Steps To Treat Heart Failure

The current heart failure rate worldwide is around 8.52 per 1000 inhabitants, making it widely prevalent across all the continents. While several heart failure treatment methods are available, it is always better to adhere to a healthy lifestyle to treat it the natural way. Heart failure is treated using the following approaches: Coronary bypass surgery … Read more